A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus.
Kim BY, Kwon HS, Kim SK, Noh JH, Park CY, Park HK, Song KH, Won JC, Yu JM, Lee MY, Lee JH, Lim S, Chun SW, Jeong IK, Chung CH, Han SJ, Kim HS, Min JY, Kim S.
Kim BY, et al. Among authors: kim s, kim sk, kim hs.
Diabetes Metab J. 2022 Nov;46(6):855-865. doi: 10.4093/dmj.2021.0264. Epub 2022 Mar 8.
Diabetes Metab J. 2022.
PMID: 35255547
Free PMC article.